Ratings by Wells Fargo (Stan Berenshteyn)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/13/2026 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/12/2026 | Claritev | CTEV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/10/2026 | Doximity Inc | DOCS | Downgrade | Underweight (Equal Weight) |
20.66 (26.35) |
27.54% | Details | |
| 8/7/2026 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/5/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/31/2026 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/30/2026 | Waystar Holding | WAY | Maintain | Overweight (Overweight) |
|
Details | ||
| 7/17/2026 | American Well Corp. | AMWL | Maintain | Overweight (Overweight) |
|
Details | ||
| 6/26/2026 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 6/24/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2026 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Phreesia Inc. | PHR | Downgrade | Equal Weight (Overweight) |
9.08 (11.84) |
30.4% | Details | |
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Equal Weight (Overweight) |
26.45 (26.35) |
-0.38% | Details | |
| 5/11/2026 | Doximity Inc | DOCS | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/8/2026 | Omada Health Inc | OMDA | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 5/6/2026 | Hinge Health Inc | HNGE | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/23/2026 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/26/2026 | Phreesia Inc. | PHR | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/19/2026 | Claritev | CTEV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 3/18/2026 | Health Catalyst Inc. | HCAT | Downgrade | Equal Weight (Overweight) |
1.22 (1.71) |
40.16% | Details | |
| 3/5/2026 | Veeva Systems | VEEV | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/4/2026 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/24/2026 | Claritev | CTEV | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/19/2026 | Waystar Holding | WAY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/6/2026 | Doximity Inc | DOCS | Maintain | Overweight (Overweight) |
|
Details | ||
| 1/20/2026 | Doximity Inc | DOCS | Upgrade | Overweight (Equal Weight) |
41.26 (26.45) |
-35.89% | Details | |
| 1/8/2026 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
17.52 (9.08) |
-48.17% | Details | |
| 1/8/2026 | Hinge Health Inc | HNGE | New Coverage | Overweight (N/A) |
49.14 (90.02) |
83.19% | Details | |
| 1/8/2026 | Waystar Holdings | WAY | New Coverage | Overweight (N/A) |
109.99 (25.76) |
-76.58% | Details | |
| 1/8/2026 | Claritev | CTEV | New Coverage | Equal Weight (N/A) |
32.68 (39.35) |
20.41% | Details | |
| 1/8/2026 | Omada Health Inc | OMDA | New Coverage | Equal Weight (N/A) |
16.57 (22.84) |
37.84% | Details | |
| 1/5/2026 | Omnicell | OMCL | Maintain | Underweight (Overweight) |
|
Details | ||
| 12/8/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/25/2025 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2025 | Health Catalyst Inc. | HCAT | Maintain | Overweight (Overweight) |
|
Details | ||
| 11/5/2025 | American Well Corp. | AMWL | Maintain | Overweight (Overweight) |
|
Details | ||
| 10/31/2025 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/28/2025 | Veeva Systems | VEEV | Maintain | Overweight (Overweight) |
|
Details | ||
| 8/26/2025 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/8/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 8/7/2025 | American Well Corp. | AMWL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/23/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/21/2025 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 6/2/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/29/2025 | Veeva Systems | VEEV | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/23/2025 | Omnicell | OMCL | Maintain | Overweight (Overweight) |
|
Details | ||
| 5/14/2025 | Omnicell | OMCL | Upgrade | Overweight (Equal Weight) |
27.46 (34.51) |
25.67% | Details | |
| 5/7/2025 | Omnicell | OMCL | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 4/29/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 4/17/2025 | Omnicell | OMCL | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 4/1/2025 | Omnicell | OMCL | Maintain | Equal Weight (Equal Weight) |
|
Details | ||
| 2/28/2025 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/26/2025 | HealthEquity, Inc | HQY | Maintain | Overweight (Overweight) |
|
Details | ||
| 2/7/2025 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/21/2025 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/13/2025 | American Well Corp. | AMWL | Upgrade | Overweight (Equal Weight) |
7.22 (12.07) |
67.17% | Details | |
| 12/17/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 12/6/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Overweight (N/A) |
|
Details | ||
| 11/8/2024 | Doximity Inc | DOCS | Upgrade | Equal Weight (Underweight) |
42.35 (26.35) |
-37.78% | Details | |
| 10/31/2024 | Omnicell | OMCL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/14/2024 | Omnicell | OMCL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/11/2024 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/2/2024 | Omnicell | OMCL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/18/2024 | Doximity Inc | DOCS | Downgrade | Underweight (Equal Weight) |
29.35 (26.35) |
-10.22% | Details | |
| 7/1/2024 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 6/28/2024 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 6/20/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2024 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/10/2024 | Health Catalyst Inc. | HCAT | Maintain | Overweight (N/A) |
|
Details | ||
| 5/7/2024 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 4/30/2024 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/25/2024 | GoodRx Holdings Inc. | GDRX | Upgrade | Overweight (Equal Weight) |
6.58 (3.46) |
-47.42% | Details | |
| 3/1/2024 | Veeva Systems | VEEV | Maintain | Overweight (N/A) |
|
Details | ||
| 3/1/2024 | GoodRx Holdings Inc. | GDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/9/2024 | Omnicell | OMCL | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/9/2024 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 1/9/2024 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 12/6/2023 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2023 | GoodRx Holdings Inc. | GDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/3/2023 | Omnicell | OMCL | Upgrade | Equal Weight (Underweight) |
29.24 (34.51) |
18.02% | Details | |
| 10/25/2023 | Veeva Systems | VEEV | Upgrade | Overweight (Equal Weight) |
197.19 (279.23) |
41.6% | Details | |
| 10/11/2023 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 9/26/2023 | Omnicell | OMCL | Maintain | Underweight (N/A) |
|
Details | ||
| 9/5/2023 | Veeva Systems | VEEV | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/10/2023 | Doximity Inc | DOCS | Maintain | Equal Weight (N/A) |
|
Details | ||
| 8/10/2023 | GoodRx Holdings Inc. | GDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/20/2023 | Omnicell | OMCL | Downgrade | Underweight (Overweight) |
67.42 (34.51) |
-48.81% | Details | |
| 6/30/2023 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/1/2023 | Doximity Inc | DOCS | Downgrade | Equal Weight (Overweight) |
36.75 (26.35) |
-28.3% | Details | |
| 4/21/2023 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 4/4/2023 | Health Catalyst Inc. | HCAT | Upgrade | Overweight (Equal Weight) |
11.87 (1.71) |
-85.59% | Details | |
| 3/7/2023 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 3/1/2023 | GoodRx Holdings Inc. | GDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/23/2023 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 2/10/2023 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/3/2023 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 1/24/2023 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 11/11/2022 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2022 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/9/2022 | GoodRx Holdings Inc. | GDRX | Maintain | Equal Weight (N/A) |
|
Details | ||
| 11/4/2022 | Omnicell | OMCL | Maintain | Overweight (N/A) |
|
Details | ||
| 10/31/2022 | Veeva Systems | VEEV | New Coverage | Equal Weight (N/A) |
171.58 (279.23) |
62.74% | Details | |
| 10/31/2022 | Health Catalyst Inc. | HCAT | Maintain | Equal Weight (N/A) |
|
Details | ||
| 10/31/2022 | Doximity Inc | DOCS | New Coverage | Overweight (N/A) |
26.31 (26.35) |
0.15% | Details | |
| 10/12/2022 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 7/5/2022 | Accolade Inc. | ACCD | Maintain | Equal Weight (N/A) |
|
Details | ||
| 5/2/2022 | Accolade Inc. | ACCD | Upgrade | Equal Weight (Underweight) |
5.56 (7.02) |
26.26% | Details |
